The Impact of SARS-CoV-2 nsp5 Resistance Mutations on Antagonism of the Innate Immune Response
1 of 9
Synthesis of P1 and Cap-P2 Fragments of Novel SARS-CoV-2 Protease Inhibitors
2 of 9
Characterizing Within-Host Evolution in Prolonged SARS-CoV-2 Infections: A Comprehensive Study Utilizing the Moran Model and Fitness Landscape Analysis
3 of 9
Transmission Bottleneck Size Estimation from De Novo Viral Genetic Variation
4 of 9
Viral Evolution During Monoclonal Antibody Treatment of SARS-CoV-2 Patients
5 of 9
Impact of Omicron sublineage, natural and vaccine-derived immunity on SARS-CoV-2 subgenomic RNA abundance
6 of 9
Investigating Novel SARS-CoV-2 Inhibitors: Identification of Potent SARS-CoV-2 Antiviral Compounds and Development of a Luciferase-Based Reporter Vector for Papain-Like Protease Inhibition
7 of 9
Understanding the rise of SARS-CoV-2 Delta variants in Atlanta and Georgia
8 of 9
Fibrinogen and Clotting Characterization in COVID-19 Patients